Skip to content

Dapagliflozin Impurity 17

Dapagliflozin Impurity 17

Product Description
CAT No.
ALN-D015026
CAS No.
2133407-75-5
Mol. F.
C21H25ClO6
Mol. Wt.
408.9
Stock
Please Inquire
Chemical Name : (2S,3S,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Smiles : O[C@@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Inchi : InChI=1S/C31H35ClO12/c1-7-38-25-11-8-22(9-12-25)14-23-15-24(10-13-26(23)32)31(43-21(6)37)30(42-20(5)36)29(41-19(4)35)28(40-18(3)34)27(44-31)16-39-17(2)33/h8-13,15,27-30H,7,14,16H2,1-6H3/t27-,28-,29+,30-,31+/m1/s1

Stability indicating rp-hplc method for simultaneous estimation of dapagliflozin and saxagliptin in pharmaceutical dosage forms

By Thota, Hanisha; Soundarya, G.nFrom Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9131-9137

Method development and validation of a stability-indicating reversed-phase liquid chromatographic method for the simultaneous estimation of metformin and dapagliflozin in presence of their degradation products

By Kotecha, Nidhi; Patel, Jayvadan – From International Journal of Pharmaceutical Sciences Review and Research (2019), 56(2), 1-6.

Validation of a newly developed stability indicating RP-liquid chromatographic method for the quantitative determination of dapagliflozin

By Sura, Sreenivasulu; Modalavalasa, Rameswara Rao; Kothapalli, ChandraSekhar B. – From Pharma Chemica (2018), 10(1), 93-102

Request For Quotation